CRISPR genetic tool will tackle cancer’s command centre – Daily Mail
Daily Mail |
CRISPR genetic tool will tackle cancer’s command centre
Daily Mail The ‘cut and paste’ gene technique famous for transforming the way we can edit DNA has set its sights on cancer’s ‘command centre’. CRISPR-Cas9 is a modern ‘cut and paste’ tool for making precise edits in DNA. Researchers used the tool to target fusion … CRISPR gene-editing tool targets cancer’s “command center”New Atlas China Is Surging Ahead In The Race To Beat Cancer With CRISPRWall Street Pit New CRISPR Technology May Be a Breakthrough for Low-Cost Disease DiagnosticsLexology (registration) Lab News –University Herald –MIT News all 12 news articles » |
|
AZ’s Imfinzi joins the immunotherapy contest
pharmaphorum The US regulator has approved AstraZeneca’s cancer immunotherapy, durvalumab – a blockbuster hopeful that could be the cornerstone of its new generation of oncology treatments. Under the brand name Imfinzi, durvalumab’s first FDA-approved use will be … |
|
PET Imaging May Predict Early Immunotherapy Response
Cancer Network Researchers provided a preclinical proof of concept for the use of granzyme B, a downstream effector of tumoral cytotoxic T cells, as an early biomarker for tumors responding to immunotherapy with checkpoint inhibitors. “In our study, we found a marker … |
The Oracle Dispatch |
US Stem Cell Inc (OTCMKTS:USRM) Explodes Higher Ahead of RMAT Decision
The Oracle Dispatch US Stem Cell Inc (OTCMKTS:USRM) is a penny player in the stem cell space that caught a massive jolt of bullish energy to start off this week. We didn’t see any clear new catalyst emerge, but the move likely hooks into the company’s near-term narrative, … Unproven stem cell therapies – promise versus evidenceBioNews US Stem Cell Inc (OTCMKTS:USRM) Extends Rise After Private Equity Firm Commits to Share PurchaseStreet Register US Stem Cell Inc (OTCMKTS:USRM) Receives Institutional Fund InjectionStockNewsUnion |
|
StemCONN Symposium Shows Connecticut is Leader in Stem Cell Research
Wesleyan Connection (blog) “Stem cell research continues to be an exciting and fast-paced field with new discoveries fueling prospects for new therapies based on regenerative medicine for a range of debilitating medical conditions, and Connecticut is at the leading edge of this … |